The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk.
Felix GrassmannAnders MälarstigLeo DahlAnnika BendesMatilda DaleCecilia Engel ThomasMarike GabrielssonÅsa K HedmanMikael ErikssonSara MargolinTzu-Hsuan HuangMikael UlfstedtSimon ForsbergPer ErikssonMattias JohanssonPer HallJochen M SchwenkKamila CzenePublished in: British journal of cancer (2023)
Our results indicate that the levels of the studied plasma proteins captured by the PEA method are unlikely to offer additional benefits for risk prediction of short-term overall breast cancer risk but could provide interesting insights into the biological basis of breast cancer in the future.